Tidal Trust III - VistaShares人工智慧超級週期ETF
US ˙ ARCA

簡介

本頁面提供了有關 Robert F Apple 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Robert F Apple已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:ATRS / Antares Pharma Inc President and CEO, Director 0
如何解讀這些圖表

以下圖表顯示了在Robert F Apple進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF內部人士買入 - 短期收益分析

在這一部分,我們分析了在 AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2016-03-18 ATRS APPLE ROBERT F 60,000 0.7200 60,000 0.7200 43,200 363 2.82 126,000 291.67

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF Insider Trades
AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2019-12-10 ATRS APPLE ROBERT F 58,524 4.7563 58,524 4.7563 278,358 99 1.75 -175,940 -63.21
2019-12-09 ATRS APPLE ROBERT F 100,000 4.6783 100,000 4.6783 467,830
2019-12-09 ATRS APPLE ROBERT F 97,000 4.6228 97,000 4.6228 448,412
2019-12-09 ATRS APPLE ROBERT F 110,000 4.5766 110,000 4.5766 503,426
2019-12-09 ATRS APPLE ROBERT F 1,000 4.7500 1,000 4.7500 4,750

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF Insider Trades
歷史內部人交易

該表格顯示了由 Robert F Apple 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -474,629 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -776,617 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -567,423 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -591,510 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -725,751 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -773,700 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -288,786 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -56,300 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -21,658 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
D - Sale to Issuer -374,099 0 -100.00 5.60 -2,094,954
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
D - Sale to Issuer -611,667 0 -100.00 5.60 -3,425,335
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
D - Sale to Issuer -1,876,693 0 -100.00 5.60 -10,509,481
2022-03-04 2022-03-03 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -37,695 2,488,360 -1.49 3.80 -143,241 9,455,768
2022-03-04 2022-03-03 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 86,814 2,526,055 3.56
2022-02-18 2022-02-16 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -34,282 2,439,241 -1.39 3.66 -125,472 8,927,622
2022-02-18 2022-02-16 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 76,893 2,473,523 3.21
2021-06-14 2021-06-13 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -40,892 2,396,630 -1.68 4.45 -181,969 10,665,004
2021-06-14 2021-06-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -58,317 2,437,522 -2.34 4.45 -259,511 10,846,973
2021-06-14 2021-06-10 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 474,629 474,629
2021-06-14 2021-06-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 248,869 2,495,839 11.08 4.42 1,100,001 11,031,608
2021-06-10 2021-06-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -44,223 2,246,970 -1.93 4.39 -194,139 9,864,198
2021-03-03 2021-03-01 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -66,330 2,291,193 -2.81 4.50 -298,485 10,310,368
2021-03-03 2021-03-01 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 152,763 2,357,523 6.93
2021-02-19 2021-02-18 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -250,000 0 -100.00
2021-02-19 2021-02-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -241,960 2,204,760 -9.89 5.00 -1,209,800 11,023,800
2021-02-19 2021-02-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -17,844 2,446,720 -0.72 5.01 -89,398 12,258,067
2021-02-19 2021-02-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -232,156 2,464,564 -8.61 5.00 -1,160,780 12,322,820
2021-02-19 2021-02-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 250,000 2,696,720 10.22 0.88 220,000 2,373,114
2021-02-19 2021-02-17 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -5,519 0 -100.00
2021-02-19 2021-02-17 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -5,519 2,446,720 -0.23 4.75 -26,215 11,621,920
2021-02-19 2021-02-17 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 5,519 2,452,239 0.23 2.62 14,460 6,424,866
2021-02-19 2021-02-17 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -116,313 2,446,720 -4.54 4.73 -550,160 11,572,986
2021-02-19 2021-02-17 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 267,878 2,563,033 11.67
2021-02-10 2021-02-10 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -7,278 0 -100.00
2021-02-10 2021-02-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -7,278 2,295,155 -0.32 4.75 -34,570 10,901,986
2021-02-10 2021-02-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 7,278 2,302,433 0.32 2.62 19,068 6,032,374
2021-02-10 2021-02-09 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -49,129 0 -100.00
2021-02-10 2021-02-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -49,129 2,295,155 -2.10 4.75 -233,363 10,901,986
2021-02-10 2021-02-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 49,129 2,344,284 2.14 2.62 128,718 6,142,024
2021-02-10 2021-02-08 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -33,574 0 -100.00
2021-02-10 2021-02-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -33,574 2,295,155 -1.44 4.75 -159,476 10,901,986
2021-02-10 2021-02-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 33,574 2,328,729 1.46 2.62 87,964 6,101,270
2020-06-15 2020-06-13 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -40,892 2,295,155 -1.75 2.78 -113,680 6,380,531
2020-06-15 2020-06-11 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 776,617 776,617
2020-06-15 2020-06-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 402,930 2,336,047 20.84 2.73 1,099,999 6,377,408
2020-06-09 2020-06-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -44,223 1,933,117 -2.24 3.13 -138,418 6,050,656
2020-06-09 2020-06-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -48,936 1,977,340 -2.42 3.12 -152,680 6,169,301
2020-02-21 2020-02-19 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -90,397 2,026,276 -4.27 3.53 -319,101 7,152,754
2020-02-21 2020-02-19 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 210,782 2,116,673 11.06
2019-12-11 2019-12-10 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -58,524 0 -100.00
2019-12-11 2019-12-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -58,524 1,905,891 -2.98 4.76 -278,358 9,064,989
2019-12-11 2019-12-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 58,524 1,964,415 3.07 3.96 231,755 7,779,083
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -1,000 0 -100.00
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -110,000 0 -100.00
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -97,000 0 -100.00
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -100,000 0 -100.00
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -1,000 1,905,891 -0.05 4.75 -4,750 9,052,982
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 1,000 1,906,891 0.05 3.96 3,960 7,551,288
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -110,000 1,905,891 -5.46 4.58 -503,426 8,722,501
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 110,000 2,015,891 5.77 2.94 323,400 5,926,720
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -97,000 1,905,891 -4.84 4.62 -448,412 8,810,553
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 97,000 2,002,891 5.09 1.66 161,020 3,324,799
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -100,000 1,905,891 -4.99 4.68 -467,830 8,916,330
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 100,000 2,005,891 5.25 1.52 152,000 3,048,954
2019-11-13 2019-11-11 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -100,000 0 -100.00
2019-11-13 2019-11-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -43,445 1,905,891 -2.23 3.77 -163,788 7,185,209
2019-11-13 2019-11-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 100,000 1,949,336 5.41 1.10 110,000 2,144,270
2019-06-14 2019-06-13 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 567,423 567,423
2019-06-14 2019-06-13 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 282,534 1,849,336 18.03 2.92 824,999 5,400,061
2019-06-11 2019-06-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -44,225 1,566,802 -2.75 2.81 -124,272 4,402,714
2019-06-11 2019-06-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -48,936 1,611,027 -2.95 2.81 -137,510 4,526,986
2019-06-04 2019-06-02 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -52,559 1,659,963 -3.07 2.79 -146,640 4,631,297
2019-02-22 2019-02-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -72,245 1,712,522 -4.05 3.20 -231,184 5,480,070
2019-02-22 2019-02-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 254,205 1,784,767 16.61
2018-08-23 2018-08-21 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -43,000 0 -100.00
2018-08-23 2018-08-21 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -43,000 1,530,562 -2.73 3.75 -161,250 5,739,608
2018-08-23 2018-08-21 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 43,000 1,573,562 2.81 0.47 20,210 739,574
2018-06-11 2018-06-08 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 591,510 591,510
2018-06-11 2018-06-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 305,556 1,530,562 24.94 2.70 825,001 4,132,517
2018-06-11 2018-06-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -32,031 1,225,006 -2.55 2.70 -86,484 3,307,516
2018-06-05 2018-06-02 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -34,402 1,257,037 -2.66 2.69 -92,541 3,381,430
2018-05-30 2018-05-28 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -13,480 1,291,439 -1.03 2.43 -32,756 3,138,197
2018-05-14 2018-05-11 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -82,500 0 -100.00
2018-05-14 2018-05-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -30,052 1,304,919 -2.25 2.52 -75,731 3,288,396
2018-05-14 2018-05-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 82,500 1,334,971 6.59 0.85 70,125 1,134,725
2018-02-26 2018-02-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -37,001 1,252,471 -2.87 2.20 -81,402 2,755,436
2018-02-26 2018-02-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 113,835 1,289,472 9.68
2017-06-12 2017-06-07 4/A ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 338,115 1,175,637 40.37 2.66 899,386 3,127,194
2017-06-09 2017-06-07 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 725,751 725,751
2017-06-09 2017-06-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award -338,115 1,175,637 -22.34 2.66 -899,386 3,127,194
2017-06-09 2017-06-02 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -38,034 837,522 -4.34 2.57 -97,747 2,152,432
2017-06-09 2017-05-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3,390 875,556 -0.39 2.51 -8,509 2,197,646
2017-06-09 2017-05-28 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -14,903 878,946 -1.67 2.51 -37,407 2,206,154
2017-06-09 2017-02-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -1,763 893,849 -0.20 2.37 -4,178 2,118,422
2017-06-09 2017-02-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 5,612 895,612 0.63
2017-04-05 2017-04-05 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -3,000 0 -100.00
2017-04-05 2017-04-05 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -3,000 890,002 -0.34 3.00 -9,000 2,670,006
2017-04-05 2017-04-05 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 3,000 893,002 0.34 1.65 4,950 1,473,453
2017-04-05 2017-04-04 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -37,000 3,000 -92.50
2017-04-05 2017-04-04 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -37,000 890,002 -3.99 3.00 -111,070 2,671,697
2017-04-05 2017-04-04 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 37,000 927,002 4.16 1.65 61,050 1,529,553
2016-12-29 2017-12-27 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -39,717 890,002 -4.27 2.35 -93,335 2,091,505
2016-12-29 2017-12-27 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 60,000 929,719 6.90 1.23 73,800 1,143,554
2016-12-29 2016-12-27 4 ATRS ANTARES PHARMA, INC.
Stock Option (Right to Buy)
M - Exercise -60,000 0 -100.00
2016-06-30 2016-06-30 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 11,223 869,719 1.31 1.05 11,784 913,205
2016-06-06 2016-06-02 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 773,700 773,700
2016-06-06 2016-06-02 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 363,150 858,496 73.31 1.12 406,728 961,516
2016-06-01 2016-05-31 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3,389 495,346 -0.68 0.92 -3,118 455,718
2016-06-01 2016-05-31 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -14,903 498,735 -2.90 0.92 -13,711 458,836
2016-06-01 2016-05-31 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3,526 513,638 -0.68 0.86 -3,032 441,729
2016-03-18 2016-03-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
P - Purchase 60,000 517,164 13.12 0.72 43,200 372,358
2016-03-11 2016-03-10 4 ATRS ANTARES PHARMA, INC.
Stock option (right to buy)
A - Award 250,000 250,000
2015-06-01 2015-05-28 4 ATRS ANTARES PHARMA, INC.
Stock option (right to buy)
A - Award 288,786 288,786
2015-06-01 2015-05-28 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 142,294 457,164 45.19
2015-06-01 2015-05-28 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3,389 314,870 -1.06 2.18 -7,388 686,417
2015-06-01 2015-05-21 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3,526 318,259 -1.10 2.10 -7,405 668,344
2015-03-12 2015-03-10 4 ATRS ANTARES PHARMA, INC.
Stock option (right to buy)
A - Award 95,500 95,500
2015-03-12 2015-02-10 4/A ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -4,779 355,455 -1.33 2.36 -11,278 838,874
2015-03-12 2015-02-10 4/A ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 12,519 360,234 3.60
2015-03-12 2014-05-21 4/A ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3,526 340,392 -1.03 2.97 -10,472 1,010,964
2015-02-12 2015-02-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -4,779 326,619 -1.44 2.36 -11,278 770,821
2015-02-12 2015-02-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 12,519 331,398 3.93
2014-06-02 2014-05-29 4 ATRS ANTARES PHARMA, INC.
Stock option (right to buy)
A - Award 56,300 1,169,982 5.06
2014-06-02 2014-05-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 32,362 441,005 7.92
2014-06-02 2014-05-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 64,725 408,643 18.82
2014-02-13 2014-02-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -7,752 343,918 -2.20 4.45 -34,496 1,530,435
2014-02-13 2014-02-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
D - Sale to Issuer -25,000 351,670 -6.64
2014-02-13 2014-02-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3,484 376,670 -0.92 4.45 -15,504 1,676,182
2014-02-13 2014-02-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 11,236 380,154 3.05
2014-01-14 2014-01-10 4 ATRS ANTARES PHARMA, INC.
STOCK OPTION (RIGHT TO BUY)
M - Exercise X -10,000 1,113,682 -0.89
2014-01-14 2014-01-10 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
S - Sale X -10,000 368,918 -2.64 5.00 -50,000 1,844,590
2014-01-14 2014-01-10 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
M - Exercise X 10,000 378,918 2.71 0.47 4,700 178,091
2013-10-16 2013-10-14 4 ATRS ANTARES PHARMA, INC.
STOCK OPTION (RIGHT TO BUY)
M - Exercise X -22,000 1,123,682 -1.92
2013-10-16 2013-10-14 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
S - Sale X -22,000 368,918 -5.63 5.05 -111,199 1,864,696
2013-10-16 2013-10-14 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
M - Exercise X 22,000 390,918 5.96 0.47 10,340 183,731
2013-06-05 2013-06-04 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -28,600 1,145,682 -2.44
2013-06-05 2013-06-04 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -28,600 368,918 -7.19 4.03 -115,126 1,485,043
2013-06-05 2013-06-04 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 28,600 397,518 7.75 0.47 13,442 186,833
2013-06-05 2013-06-03 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -86,400 1,174,282 -6.85
2013-06-05 2013-06-03 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -86,400 368,918 -18.98 4.01 -346,792 1,480,763
2013-06-05 2013-06-03 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 86,400 455,318 23.42 0.47 40,608 213,999
2013-05-24 2013-05-22 4 ATRS ANTARES PHARMA, INC.
Stock option (right to buy)
A - Award 59,524 1,260,682 4.96
2013-05-24 2013-05-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 33,670 368,918 10.04
2013-05-24 2013-05-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 33,670 368,918 10.04
2013-05-08 2013-05-06 4 ATRS ANTARES PHARMA, INC.
STOCK OPTION (RIGHT TO BUY)
M - Exercise X -10,000 1,201,158 -0.83
2013-05-08 2013-05-06 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
S - Sale X -10,000 301,578 -3.21 4.02 -40,157 1,211,047
2013-05-08 2013-05-06 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
M - Exercise X 10,000 311,578 3.32 0.47 4,700 146,442
2013-01-10 2013-01-08 4 ATRS ANTARES PHARMA, INC.
STOCK OPTION (RIGHT TO BUY)
M - Exercise X -25,000 1,211,158 -2.02
2013-01-10 2013-01-08 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
S - Sale X -25,000 310,270 -7.46 4.01 -100,290 1,244,679
2013-01-10 2013-01-08 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
M - Exercise X 25,000 335,270 8.06 0.47 11,750 157,577
2012-12-06 2012-12-04 4 ATRS ANTARES PHARMA, INC.
STOCK OPTION (RIGHT TO BUY)
M - Exercise X -25,000 1,236,158 -1.98
2012-12-06 2012-12-04 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
S - Sale X -25,000 310,270 -7.46 4.00 -100,000 1,241,080
2012-12-06 2012-12-04 4 ATRS ANTARES PHARMA, INC.
COMMON STOCK
M - Exercise X 25,000 335,270 8.06 0.47 11,750 157,577
2012-07-10 2012-07-06 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 21,658 1,261,158 1.75
2012-07-10 2012-07-06 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 25,039 310,270 8.78
2012-05-21 2012-05-17 4 AIS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 110,000 1,239,500 9.74
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)